Quoin Pharmaceuticals gets FDA rare pediatric disease designation for QRX003
Quoin Pharmaceuticals said the FDA granted Rare Pediatric Disease designation for QRX003 in Peeling Skin Syndrome. The item cites an original SEC filing and does not provide additional terms.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.